Venus gets DCGI approval for phase III trial of cancer detection NCE
Venus is planning to launch this NCE by last quarter of 2013 in India
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Piramal’s subsidiary, DRG acquires Abacus International
Acquisition adds significant global market access capabilities to DRG
The grim future
Rephrasing a common proverb, a lean compromise is better than a fat disguise. However, people of India do not seem to have taken…
DCGI to be competent national authority to certify API exports to EU
Draft guidelines for certification as per Falsified Medicines Directive, to be finalised by Jan 2013
Piramal Enterprises Healthcare in alliance with Fujifilm Diosynth Biotechnologies
Will offer the seamless contract development and manufacture of antibody drug conjugates
Cipla Palliative Care Centre completes 15 years of caring for advanced stage cancer patients
Announces another major price reduction on select cancer drugs